The Scientist - Home

A pill is shown on a blue technical background. One half of the pill has a DNA helix on it, and the other half has a depiction of a computer chip, representing the role of artificial intelligence in drug development.
| 3 min read
2026 will be the year that artificial intelligence accelerates multiple aspects of the drug discovery and development pipeline, industry leaders predict.

Latest

The Scientist Placeholder Image

NAS Research Funding Proposal Aims Toward Long-Term Stability

The Scientist Placeholder Image

Large-Scale Mentoring Program Succeeds For Women Scientists

The Scientist Placeholder Image

The Glass Ceiling: It Remains Firmly In Place

The Scientist Placeholder Image

Observers Have Mixed Views On Clinton's Green Policies

The Scientist Placeholder Image

Notebook

The Scientist Placeholder Image

Career Opportunities For Toxicologists On The Rise, With Demand For Their Expertise Rapidly Growing

The Scientist Placeholder Image

White House Keeping Low Profile As Hunt For Healy's Successor At NIH Appears To Be Reaching Final Stage

The Scientist Placeholder Image

Scientific Merit, Rather Than Morals, Guides Use Of Animals In Lab Research

The Scientist Placeholder Image

Some Lingering Controversies Confront Bruce Alberts As He Succeeds Frank Press At National Academy Helm

The Scientist Placeholder Image

Columbia Emeritus Chemistry Professor Receives $225,000 Robert A. Welch Award, UC-Berkeley Neurobiologist Gets Prize Honoring Silvio Conte

The Scientist Placeholder Image

Notebook

The Scientist Placeholder Image

Legions Of Life Scientists Will Be Called To The Front, As War On AIDS Intensifies

Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies